News

Video February 24, 2021

State of Stem Cell Symposium

Watch presentations from The State of Stem Cell Symposium

iPS Cell Research Center Stem Cells/iPSCs

Gladstone in the News February 3, 2021

San Francisco Researchers Use Genetic Clues to Identify Possible Drug for Treating Heart Conditions

ABC7 News—Gladstone President Deepak Srivastava, MD, a pediatric cardiologist, explains how his group discovered a potential new drug to treat a debilitating disease due to the hardening of heart valves.

Gladstone Experts Congenital Heart Disease Cardiovascular Disease Srivastava Lab Stem Cells/iPSCs

Video January 20, 2021

The Convergence of CRISPR and Human Stem Cells

Gladstone President Deepak Srivastava moderated a conversation with Jennifer Doudna and Shinya Yamanaka.

Doudna Lab Yamanaka Lab CRISPR/Gene Editing Stem Cells/iPSCs

Article December 14, 2020

Study Reveals Networks of Genes Involved in Congenital Heart Disease

The findings could point toward new ways to prevent or treat one of the most common birth defects

News Release Research (Publication) Congenital Heart Disease Cardiovascular Disease Bruneau Lab Human Genetics Stem Cells/iPSCs

Article December 10, 2020

A Potential Therapy for One of the Leading Causes of Heart Disease

A drug candidate found by Gladstone researchers could help prevent tens of thousands of heart surgeries every year

News Release Research (Publication) Heart Failure Cardiovascular Disease Srivastava Lab Theodoris Lab AI CRISPR/Gene Editing Disease Models Stem Cells/iPSCs

Gladstone in the News November 1, 2020

California Prop 14 May Change Lives of Sick Kids, Keep Taxpayer Funding of Stem Cell Therapy Research

USA Today—California Proposition 14 put funding for the Stem Cell Research Institute on the ballot this year. Gladstone President Deepak Srivastava, MD, explains how previous funding for stem cell research in California has helped bring the field to a point where stem cell–based therapies are now possible.

Gladstone Experts Cardiovascular Disease Srivastava Lab Stem Cells/iPSCs

Gladstone in the News October 18, 2020

Conservatives Confront Moral Dilemma of Vaccines and Treatments Derived from Fetal Tissue Cells

abc News—In 2019, the Trump administration suspended federal funding for research involving fetal tissue. Gladstone President Deepak Srivastava explains that if the funding ban had been in place over the last few decades, many important drugs—including treatments for COVID-19—would not have been developed.

Gladstone Experts COVID-19 Roddenberry Stem Cell Center Srivastava Lab Stem Cells/iPSCs

Gladstone in the News April 9, 2020

Coronavirus Treatment: San Francisco Scientists’ Stem Cell Research Could Help in COVID-19 Fight

ABC7 News—While some COVID-19 cases are severe and cause rapid decline, other patients experience only mild symptoms. Gladstone President Deepak Srivastava explains how stem cell research could help explain this phenomenon, and lead to targeted treatments.

Research (Publication) COVID-19 Stem Cells/iPSCs

Gladstone in the News April 7, 2020

Tackling Heart Disease

The Stem Cell Podcast—Gladstone President Deepak Srivastava describes his work using human induced pluripotent stem cells to investigate the gene networks that dictate cell fate decisions, and how this research could lead to therapeutics for congenital heart disease and heart failure. He also describes the importance of stem cell research in fighting the COVID-19 pandemic.

Gladstone Experts COVID-19 Heart Failure Congenital Heart Disease Cardiovascular Disease Roddenberry Stem Cell Center Srivastava Lab Stem Cells/iPSCs

Article January 16, 2020

Measuring Research Impact

Gladstone researcher Alex Pico helped develop a new way to measure the difference one discovery can make on science around the world.

Research (Publication) Data Science and Biotechnology Big Data Stem Cells/iPSCs

Gladstone in the News January 14, 2020

Stem Cell Patterning by Automated Design

The Stem Cell Podcast—Gladstone Senior Investigator Todd McDevitt describes his work using stem cells to understand how tissues grow and organize themselves, and how these efforts lay the groundwork for regenerative medicine therapies.

Gladstone Experts Heart Failure Cardiovascular Disease McDevitt Lab Organoids Stem Cells/iPSCs

Article December 3, 2019

Gladstone Signs Agreement with Kyoto University for an On-site CiRA Laboratory

The Center for iPS Cell Research and Application (CiRA) at Kyoto University opened a new on-site laboratory at Gladstone Institutes.

Institutional News iPS Cell Research Center Yamanaka Lab Stem Cells/iPSCs

Article November 20, 2019

Machine, Meet Stem Cells

Gladstone researchers used a machine-learning approach to discover new ways of controlling the spatial organization of induced pluripotent stem cells.

News Release Research (Publication) Conklin Lab McDevitt Lab AI Big Data CRISPR/Gene Editing Imaging

Article November 19, 2019

Predicting Alzheimer’s Disease-like Memory Loss before It Strikes

New study shows how patterns in brain activity can be an early predictor of Alzheimer’s symptoms.

News Release Research (Publication) Alzheimer’s Disease Dementia Neurological Disease Center for Systems and Therapeutics Huang Lab Stem Cells/iPSCs

Article November 12, 2019

Gordon Keller: Laying a Foundation for Stem Cell Therapeutics

Gordon Keller, recipient of the 2019 Ogawa-Yamanaka Stem Cell Prize, discusses challenges and successes during his 30 years of pioneering research on stem cells.

Ogawa Stem Cell Prize Profile Roddenberry Stem Cell Center Stem Cells/iPSCs